CDKN2A and neoplasm of thorax: Among all the tested cases with SMARCA4‐deficient thoracic tumors, TP53 was the most frequently mutated gene (81%), followed by CDKN2A (26%), KRAS (15%), STK11 (15%), NF1 (15%), and PTEN (11%).